BSE filing, NSE: KBSINDIA. Summary written from the filing by ALFA Finder's alert engine.
KBS India Ltd: key numbers
- Share price
- ₹1.28
- Market cap
- ₹13.85 Cr
- Revenue (annual)
- ₹2.34 Cr
- Net profit (annual)
- ₹0.09 Cr
- P/E (TTM)
- -213.7×Sector 19.7×
- Promoter holding
- 28.77%+0.00% QoQ
- FII holding
- 5.69%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from KBS India Ltd
All →KBS India Annual General Meeting
KBS India Ltd held its AGM and passed four resolutions, including the issuance of 2.50 lakh non-convertible redeemable preference shares to its promoter.
- Value
- ₹2.50 Cr
KBS India Annual General Meeting
KBS India Limited successfully concluded its 40th Annual General Meeting on 18th September, 2026. Shareholders transacted agenda items including preference share issuance and related party approvals.
KBS India Annual General Meeting
KBS India Limited's Annual General Meeting notice includes an agenda to issue 2.5 lakh preference shares worth Rs. 2.50 Crore to a promoter.
- Value
- ₹2.50 Cr
KBS India Annual General Meeting
KBS India Limited has issued a notice for its 40th Annual General Meeting to be held on September 18, 2026, through video conferencing.
KBS India Board Meeting Outcome
KBS India Ltd approved its Directors Report and scheduled the AGM. The Board also approved raising ₹2.50 Crore via a preferential issue of preference shares.
- Value
- ₹2.50 Cr
KBS India Other Announcement
KBS India Limited submitted the Statement of Impact of Audit Qualifications for the quarter ended June 30, 2026, as required by regulatory norms.
Other other announcement announcements
All →Senores Pharmaceuticals Other Announcement
Senores Pharmaceuticals reported no deviation in utilising the Rs 95 Crore raised via a preferential warrant issue for the quarter ended September 30, 2026. Audit Committee reviewed the statement and the Board took it on record.
- Value
- ₹95.00 Cr
NIIT Learning Systems Other Announcement
NIIT Learning Systems board recommended appointing Price Waterhouse Chartered Accountants LLP as statutory auditor for five years from the 25th AGM. The incumbent S. R. Batliboi firm completes its second term.
- Execution
- Five consecutive years, from the 25th AGM (2027) until the 30th AGM (2032)
Senores Pharmaceuticals Other Announcement
Senores Pharmaceuticals appointed Talati and Talati LLP as Statutory Auditor for a 60-month term, effective 29 October 2026. The appointment was approved at the board meeting held the same day.
- Execution
- 60 months
Magson Retail & Distribution Other Announcement
Magson Retail submitted its Regulation 76 Reconciliation of Share Capital Audit Report for the quarter ended 30 September 2026. The report shows a 9,15,940 share difference between issued and listed capital, pending exchange listing approval.
Ekennis Software Service Other Announcement
Ekennis Software declared Regulation 23 related party transaction rules non-applicable for H1 FY27, as its paid-up capital and net worth are below SME thresholds. A CA certificate confirms the figures.
Shri Gang Industries and Allied Products Other Announcement
Shri Gang Industries filed its quarterly shareholding pattern dated 23 October 2026. The filing notes pledges, a warrant conversion, and a deceased promoter's shares moved to a nominee.